ONCOK9

PetDx® - The Liquid Biopsy Company for Pets™ is a San Diego-based molecular diagnostics company. Its flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, empowering veterinarians to provide superior care to canine patients... OncoK9 is a multi-cancer early detection (MCED) test for the detection and characterization of cancer-associated genomic alterations in DNA isolated from canine whole blood samples, using next-generation sequencing (NGS) technology. OncoK9 is intended for use in dogs who are at higher risk of cancer. As with any laboratory test, OncoK9 results should be interpreted by a veterinarian in the context of each patient's medical history and clinical presentation.

Also known as: PetDx

Primary location: La Jolla United States